| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |